Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
This study is currently recruiting participants.
Verified July 2016 by S. Middeldorp, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
First Posted: April 11, 2013
Last Update Posted: July 13, 2016
Netherlands Organisation for Scientific Research
CHU of Saint Etienne (sponsor of the French part of the study)
Information provided by (Responsible Party):
S. Middeldorp, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2020|
|Estimated Primary Completion Date:||December 2019 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Middeldorp S. New studies of low-molecular-weight heparin in pregnancy. Thromb Res. 2015 Feb;135 Suppl 1:S26-9. doi: 10.1016/S0049-3848(15)50436-2. Epub 2015 Feb 9. Review.